vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $692.4M, roughly 1.4× OCEANEERING INTERNATIONAL INC). OCEANEERING INTERNATIONAL INC runs the higher net margin — 5.2% vs 0.7%, a 4.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 3.6%). Astrana Health, Inc. produced more free cash flow last quarter ($-6.0M vs $-76.5M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 1.8%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
ASTH vs OII — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $692.4M |
| Net Profit | $6.6M | $36.1M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | 5.2% |
| Revenue YoY | 42.9% | 3.6% |
| Net Profit YoY | 184.4% | -28.3% |
| EPS (diluted) | $0.12 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $692.4M | ||
| Q4 25 | $950.5M | $668.6M | ||
| Q3 25 | $956.0M | $742.9M | ||
| Q2 25 | $654.8M | $698.2M | ||
| Q1 25 | $620.4M | $674.5M | ||
| Q4 24 | $665.2M | $713.5M | ||
| Q3 24 | $478.7M | $679.8M | ||
| Q2 24 | $486.3M | $668.8M |
| Q1 26 | — | $36.1M | ||
| Q4 25 | $6.6M | $177.7M | ||
| Q3 25 | $373.0K | $71.3M | ||
| Q2 25 | $9.4M | $54.4M | ||
| Q1 25 | $6.7M | $50.4M | ||
| Q4 24 | $-7.8M | $56.1M | ||
| Q3 24 | $16.1M | $41.2M | ||
| Q2 24 | $19.2M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 19.8% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 21.3% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | 19.9% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | — | 18.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 9.8% | ||
| Q3 25 | 2.0% | 11.6% | ||
| Q2 25 | 3.1% | 11.3% | ||
| Q1 25 | 3.3% | 10.9% | ||
| Q4 24 | 0.1% | 10.9% | ||
| Q3 24 | 5.9% | 10.5% | ||
| Q2 24 | 6.2% | 9.0% |
| Q1 26 | — | 5.2% | ||
| Q4 25 | 0.7% | 26.6% | ||
| Q3 25 | 0.0% | 9.6% | ||
| Q2 25 | 1.4% | 7.8% | ||
| Q1 25 | 1.1% | 7.5% | ||
| Q4 24 | -1.2% | 7.9% | ||
| Q3 24 | 3.4% | 6.1% | ||
| Q2 24 | 3.9% | 5.2% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.12 | $1.75 | ||
| Q3 25 | $0.01 | $0.71 | ||
| Q2 25 | $0.19 | $0.54 | ||
| Q1 25 | $0.14 | $0.49 | ||
| Q4 24 | $-0.14 | $0.55 | ||
| Q3 24 | $0.33 | $0.40 | ||
| Q2 24 | $0.40 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $488.8M |
| Stockholders' EquityBook value | $779.3M | $1.1B |
| Total Assets | $2.2B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | $695.9M | ||
| Q3 25 | $463.4M | $7.0M | ||
| Q2 25 | $342.1M | $7.0M | ||
| Q1 25 | $260.9M | $7.0M | ||
| Q4 24 | $290.8M | $504.5M | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | — | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $779.3M | $1.1B | ||
| Q3 25 | $775.5M | $907.7M | ||
| Q2 25 | $765.5M | $842.1M | ||
| Q1 25 | $745.4M | $773.1M | ||
| Q4 24 | $712.7M | $714.3M | ||
| Q3 24 | $704.6M | $698.0M | ||
| Q2 24 | $678.9M | $651.0M |
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.2B | $2.7B | ||
| Q3 25 | $2.2B | $2.5B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | $1.3B | $2.3B | ||
| Q4 24 | $1.4B | $2.3B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | $-76.5M |
| FCF MarginFCF / Revenue | -0.6% | -11.1% |
| Capex IntensityCapex / Revenue | 0.3% | 2.5% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $221.1M | ||
| Q3 25 | $10.0M | $101.3M | ||
| Q2 25 | $90.9M | $77.2M | ||
| Q1 25 | $16.6M | $-80.7M | ||
| Q4 24 | $-10.9M | $128.4M | ||
| Q3 24 | $34.0M | $91.9M | ||
| Q2 24 | $23.2M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | $-6.0M | $190.7M | ||
| Q3 25 | $7.4M | $77.0M | ||
| Q2 25 | $89.5M | $46.9M | ||
| Q1 25 | $13.6M | $-106.8M | ||
| Q4 24 | $-13.5M | $94.5M | ||
| Q3 24 | $31.7M | $67.0M | ||
| Q2 24 | $20.4M | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | -0.6% | 28.5% | ||
| Q3 25 | 0.8% | 10.4% | ||
| Q2 25 | 13.7% | 6.7% | ||
| Q1 25 | 2.2% | -15.8% | ||
| Q4 24 | -2.0% | 13.2% | ||
| Q3 24 | 6.6% | 9.9% | ||
| Q2 24 | 4.2% | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 0.3% | 4.6% | ||
| Q3 25 | 0.3% | 3.3% | ||
| Q2 25 | 0.2% | 4.3% | ||
| Q1 25 | 0.5% | 3.9% | ||
| Q4 24 | 0.4% | 4.7% | ||
| Q3 24 | 0.5% | 3.7% | ||
| Q2 24 | 0.6% | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.24× | ||
| Q3 25 | 26.69× | 1.42× | ||
| Q2 25 | 9.65× | 1.42× | ||
| Q1 25 | 2.48× | -1.60× | ||
| Q4 24 | — | 2.29× | ||
| Q3 24 | 2.11× | 2.23× | ||
| Q2 24 | 1.21× | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
OII
Segment breakdown not available.
